Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway.

Authors:
Per Sverre Persett
Per Sverre Persett
Oslo University Hospital
Norway
Ritva Karinen
Ritva Karinen
Norwegian Institute of Public Health
Norway
Fridtjof Heyerdahl
Fridtjof Heyerdahl
Ullevaal University Hospital
Norway
Knut Erik Hovda
Knut Erik Hovda
Ullevaal University Hospital
Norway

Clin Toxicol (Phila) 2017 Aug 13;55(7):636-644. Epub 2017 Apr 13.

f The Norwegian CBRNe Centre of Medicine, Department of Acute Medicine , Oslo University Hospital , Oslo , Norway.

Context: Recreational drug toxicity is frequent. Availability of new psychoactive substances is steadily increasing. However, data with verified analyses from clinical settings are limited. To evaluate the impact of novel psychoactive substances (NPS) on recreational drug toxicity in Oslo, Norway, we analysed samples from a selection of patients.

Methods: All the patients presenting with recreational drug toxicity at the Oslo Accident and Emergency Outpatient Clinic (OAEOC) and at the Oslo University Hospital (OUH) were registered from April through September 2014. Oral fluid samples were collected at the OAEOC. Blood samples were collected at the OUH. The samples were screened using ultra-high performance liquid chromatography - tandem mass spectrometry (UHPLC-MS/MS).

Results: Nine hundred and sixty-four cases were included, 841 (87.2%) at the OAEOC and 123 (12.8%) at the OUH. A total of 55 oral fluid samples (OAEOC) and 103 blood samples (OUH) could be analysed. NPS were not clinically suspected in any of the screened cases. At the outpatient clinic, the most commonly found substances were clonazepam in 42/55 (76.4%) cases, amfetamines in 40/55 (72.7%) and heroin in 39/55 (70.9%). In seven (12.7%) cases NPS were detected: 4-methylamfetamine in three cases, dimethyltryptamine in two, methylone in one, and N,N-dimethyl-3,4-methylenedioxyamfetamine in one. Among the hospital patients, the most commonly found substances were clonazepam in 51/103 (49.5%) cases, amfetamines in 48/103 (46.6%), heroin in 31/103 (30.1%), and diazepam in 30/103 (29.1%). In five (4.9%) cases NPS were detected: JWH-210 in two cases, AM-2201 in two, and 5-EAPB in one.

Conclusion: NPS were clinically not suspected, though found in eight percent of cases. Still, the vast majority of patients treated for recreational drug toxicity in Oslo have taken classical drugs. Management of these patients should be based on their clinical condition. However, it is highly important to be alert to atypical presentations possibly resulting from unsuspected drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15563650.2017.1312002DOI Listing
August 2017
12 Reads

Publication Analysis

Top Keywords

drug toxicity
20
recreational drug
20
toxicity oslo
16
psychoactive substances
12
cases
9
substances clonazepam
8
cases amfetamines
8
outpatient clinic
8
cases nps
8
nps detected
8
commonly substances
8
nps clinically
8
samples collected
8
impact novel
8
blood samples
8
novel psychoactive
8
fluid samples
8
oslo norway
8
oral fluid
8
clinically suspected
8

References

(Supplied by CrossRef)

2015

2016

Similar Publications